Infirst’s Flarin Lipid Ibuprofen Trialled As COVID-19 Treatment
A clinical trial will explore the effectiveness of OTC ibuprofen drug Flarin in reducing COVID-19 related respiratory failure in hospitalized patients, following "compelling" pre-clinical data.
You may also be interested in...
HBW Insight Exclusive: Flarin boss Andrew Macmillen on competing with the big OTC incumbents as a lean, innovation-focused company.
Clincal studies planned to test if povidone-iodine, marketed widely as consumer health products under the brand name Betadine, can prevent infection with the novel coronavirus.
ASA tells Infirst that use of the word "different" in marketing implies its Flarin analgesic is more effective than other ibuprofen OTC drugs sold in the UK.